Gerry Smith

The DCRO Risk Governance Institute

The DCRO Risk Governance Institute

Award of the prestigious Certificate in Risk Governance to Gerry Smith of Phoenix, AZ, USA

Gerry brings chief executive and board experience to a perspective on risk that cuts across multiple industries and business plans, and this program further enhances the value he brings.”

— David R. Koenig, President and CEO of The DCRO Institute.

COLUMBUS, OH, UNITED STATES, March 31, 2021 / — The DCRO Institute, a global non-profit focused on the advanced development of current and prospective board members, announced today the award of the prestigious Certificate in Risk Governance to Gerry Smith of Phoenix, Arizona, USA.

The Certificate in Risk Governance is awarded to those who have successfully completed an intensive 17-course education program and evaluation. The curriculum is designed for board members who seek to advance the governance of risk-taking at their organizations and is taught by some of the world’s leading figures in risk governance. The program features lessons by nearly 50 board members, c-level executives, and well-known authors from five continents.

“We are pleased to award this distinction to Gerry as a board member committed to continuous improvement of his skills,” said David R. Koenig, President and Chief Executive Officer of The DCRO Institute. “Gerry brings chief executive and board experience to a perspective on risk that cuts across multiple industries and business plans, and this program further enhances the value he brings to his discussions with board colleagues,” he continued.

“For anyone that is trying to improve their corporate governance skills, I would definitely recommend the DCRO Institute program,” said Mr. Smith. “Completing the program will certainly enhance any executive’s ability to serve in a board or risk management executive position,” he continued.

The Certificate in Risk Governance program, also known as The Board Members’ Course on Risk™, is unique. No course on risk for board members as robust as this – depth, practicality, and global expertise – exists anywhere else. The fundamental Duty of Care for directors around risk is to ensure that our organizations are taking risk well in pursuit of our goals and ambitions. This course furthers the fulfillment of that duty. Information about the Certificate in Risk Governance program is available for download.

About the DCRO Institute – The DCRO Institute teaches current and aspiring board members to govern their organization’s risk-taking, so they are more likely to achieve their goals. Our goal, which is emblazoned on our logo, is to help organizations Innovate, Sustain, and Create Value. Visit to learn more.

David R. Koenig
The DCRO Institute
+1 612-286-1776
email us here
Visit us on social media:

Learn more about the Certificate in Risk Governance program

Source: EIN Presswire

The Hard Truth: Delta 8 Sales Needed to Work Through a Million Lbs of Oversupply

The Hard Truth: Delta 8 Sales Needed to Work Through a Million Lbs of Oversupply

DENVER, CO, UNITED STATES, March 31, 2021 / — The March edition of the PanXchange®: Hemp Benchmarks and Analysis was released today and is accessible to subscribers on the PanXchange website. In addition to its usual suite of 12 benchmark prices covering the cannabinoid market, fiber, and hemp grain, the report discusses shocking follow-up numbers to our December report that discussed 2020 supply, demand, and deal flow in depth.

Today, the PanXchange team has found that over millions of pounds of oversupply have accrued since the 2019 crop and has left the hemp industry itching for a way out. PanXchange took apart the data to learn exactly how many kilograms of Delta 8 products would need to be sold to get rid of this oversupply. Unlock your exclusive content by subscribing here!

Julie Lerner, PanXchange’s CEO and Founder, explains, “It’s not the news that people want to hear, but it’s important to quantify the amount of oversupply in cannabinoids and how long it will take us to work through it. I’m proud of the PanXchange team for providing the industry with the most accurate benchmarks and timely fundamental analysis.”

Those following PanXchange’s progress in US hemp may remember that in December, the company released its second annual report that issued cannabinoid (CBD) market demand estimates by volume of hemp instead of an addressable market value based on retail consumer product prices. The historical report is accessible on the website to subscribers and also included:

– PanXchange hemp production estimates by sector compared with FSA
– Charlotte’s Web market share and what their financial statements reveal
– The extent of the 2019 & 2020 oversupply and where inventory is building as a result
– Processing capacity, which was a completely elusive topic in 2019
– Effects of COVID on overall demand compared with marijuana sales
– What it all means for 2021 prices

In addition, each monthly PanXchange Hemp®: Benchmarks & Analysis report includes 12 benchmark prices, including True hemp and hemp grain, price indications on smokeable flower and other specialty hemp strains, updates on legislation, plantings, growing conditions, and many other aspects affecting physical deal flow and prices.

About PanXchange:

PanXchange is a market structure solution for physical commodities that feed and fuel the world. Centered around its institutional-grade electronic negotiating and trading platform designed by the company founder, a former executive with Cargill, RBS Sempra, and XL Financial, it offers instant market access and price discovery. Concerning its benchmark pricing services, PanXchange is a Price Discovery Platform, not a price reporting agency (PRA), because it is backed by actual physical commodity trade activity, not just reported values, which often includes brokers and analysts. PanXchange serves the US industrial hemp market, the 120-million-ton specialty sand (proppants) market for US oil and gas extraction, and East African agricultural markets.

For the latest PanXchange news, please visit our news page:
To learn more about our work, please visit our PanXchange Favorites page:

Julie Lerner
Visit us on social media:

Source: EIN Presswire

Sologenic Launches DEX: One Step Closer to Allow Users to Trade Tokenized Stocks 24/7

Sologenic announced the launch of the highly anticipated Sologenic Decentralized Exchange (DEX) on the blazingly fast and secure XRP Ledger Blockchain.

TALLINN, ESTONIA, March 31, 2021 / — Sologenic announced the launch of the highly anticipated Sologenic Decentralized Exchange (DEX) on the blazingly fast and secure Blockchain, XRP Ledger, allowing users to trade Cryptocurrencies including SOLO, XRP, and the upcoming Tokenized Assets such as Stocks, ETFs, and commodities from top global exchanges 24/7 from every corner of the globe.

The Sologenic DEX is an advanced decentralized trading platform that allows users to trade (peer-to-peer) any fraction of tokenized assets, SOLO, and XRP while having custody of their private keys which provides maximum security and trust.

Sologenic DEX features:
– Dynamic & fully customizable widgets in the trading terminal
– Professional charting tools with candles as low as 1 minute and live order books
– Support for several languages such as English, Spanish, Japanese, and many more
– Light / Dark Themes
– Removes barriers to entry for a private, safe and secure trading experience that is not controlled by any centralized entity
– Support for other wallets (Ledger, XUMM and…)
– Fees as low as $0.000005
– Transaction finality of ~3 seconds

With the Sologenic DEX, users can safely manage their assets and trade on the DEX by connecting to their preferred wallets such as SOLO Wallet, Ledger Devices, D’cent, XUMM and more to be added.

The Sologenic Tokenization Platform is available to the public to practice trading and tokenizing stocks from Nasdaq and NYSE. You can check out the testnet here. While the practice mode is currently available, the Sologenic tokenization platform is currently awaiting its licenses to be granted to go live.

“With the decentralized finance (DeFi) boom of 2020, a number of DEXs have sprung up, but what makes Sologenic DEX stand out is the ability to trade the upcoming Tokenized Stocks freely and fractionally. The development of Sologenic core component, tokenization platform, has been completed and currently we’re waiting for the approval of the MiFID license by Financial Supervisory Authority (FSA) to go live.”
– Said Bob Ras, Co-Creator

The Sologenic DEX web platform is now accessible through An upcoming update in April 2021 will introduce the DEX into the new SOLO Wallet IOS and Android platforms.

To learn more visit:

About Sologenic:
Sologenic tokenization ecosystem facilitates investing and trading between crypto and non-blockchain assets such as stocks, ETFs, and commodities from top 30+ global stock exchanges. Learn more on

Chichi Pensuk

Source: EIN Presswire

Alacrinet Consulting Services Acquires Security Research Firm Chamber’s Key Cybersecurity

Alacrinet Logo

Launching ‘Alacrinet Security Labs’ to publish new research and complement our expanding cybersecurity portfolio of services and solutions.

The knowledge and skills that the Chambers Key team brings, combined with our expertise in implementing and managing the leading security solutions, brings a lot of added value to our clients.”

— Brian Bouchard

PALO ALTO, CALIFORNIA, UNITED STATES, March 31, 2021 / — Alacrinet Consulting Services, LLC is excited to announce the expansion of their cybersecurity portfolio, which will now include security research and development along with their existing security solutions and services. With the acquisition of Chamber’s Key and their team of skilled researchers and penetration testers, Alacrinet combines their existing cybersecurity expertise with hands-on technical research to deliver industry-leading cybersecurity services.

“We’ve seen a tremendous response to the penetration testing services we launched last year and want to take it to the next level with in-house research and development,” says Brian Bouchard, President and CEO of Alacrinet. “The knowledge and skills that the Chamber's Key team brings, combined with our expertise in implementing and managing the leading security solutions, brings a lot of added value to our clients.”

With this acquisition, we will be launching the Alacrinet Security Labs. This division will be dedicated to researching new Common Vulnerabilities and Exposures (CVEs) and publishing our findings with the details to remediate and mitigate risks.

According to Mike Pena, CEO of Chamber’s Key and now VP of Penetration Testing at Alacrinet, “Alacrinet Security Labs will take a customer-focused approach to security research. This acquisition aligns our common goal of creating a premier client-focused penetration testing research firm where the client experience is just as important as the reporting.”

In the coming months, we’re excited to build a team of highly skilled researchers. “As we grow the team we’re also looking to implement a training course to certify the skill level and experience of our penetration testers. In conjunction with their technical certifications, our training course will provide penetration testers with best practices and processes that connect their testing with the business goals and security solutions.”

Alacrinet is a Palo Alto-based IT Security consulting firm serving enterprise clients across all industries nationwide. As a full-service partner, Alacrinet helps address clients’ security challenges by identifying areas of risk and providing the knowledge and recommendations to implement a strong security posture. We’ve established three key security pillars – Solutions, Services, and Staffing – to meet the demands in all areas of cybersecurity.
Learn more at

Chamber's Key Cybersecurity (Chamber's Key) is a boutique penetration testing research firm based out of the Pacific Northwest in the greater Seattle area. With significant consulting experience in industries such as manufacturing, public sector, fintech, and healthcare, Chamber's Key is uniquely positioned to help organizations mature their overall security posture. Chamber's Key's client-focused approach incentivizes their researchers to go beyond the discovery and exploitation of vulnerabilities but also provide the client with all the consulting necessary to harden their environments.

Lisa Cogliati
email us here
Visit us on social media:

Source: EIN Presswire

Wolfe Investments Purchases Historic U.S. Post Office and Courthouse Building in Downtown Dallas

The landmark purchase is the company’s second largest acquisition to date, just behind the historic Rockefeller building in Cleveland, Ohio.

PLANO, TEXAS, UNITED STATES, March 31, 2021 / — In a game-changing move, Wolfe Investments is pleased to announce it has purchased the historic U.S. Post Office and Courthouse building in downtown Dallas.

Wolfe Investments is a private equity real estate investment firm located in Plano, Texas. Established in 2012, the company provides investment opportunities to sophisticated and accredited investors across four categories: multifamily, development, commercial real estate funds, and hard money lending. From the beginning, Wolfe Investments has aligned its interests with its investors’ by investing alongside them in every offering. Today, the company is a diversified real estate investment firm with nationwide holdings and a growing team.

In the company’s latest move, Wolfe Investments has recently purchased the old U.S. Post Office and Courthouse, which was originally constructed in 1929. The building is one of the most significant architectural buildings in the state of Texas and is a registered historic national landmark. Built as the largest federal building in the South, significant entities housed on site included not only the US Postal Service and Federal Court System, but also the Department of Justice (FBI), and the Internal Revenue Service, among many others. Since its completion, the building has been reallocated to serve a variety of purposes and has seen multiple cases of national importance between its walls and in its courtroom.

“In 2007, Todd Interests acquired the building and 400 North Ervay underwent a total renovation, restoration, and repurposing that included the designation of the building as a local, state, and National Historic landmark,” says founder of Wolfe Investments, Kenny Wolfe. “Currently, the building is utilized as mixed-use space housing luxury apartments and a venue that has hosted a number of high-profile events in Dallas. Though it has been fully renovated, the main corridor, lobby, and historic courtrooms have been meticulously restored of their classical Italian renaissance architecture, terracotta floors with inlaid patterned marble, hardwood flooring, marble wainscoting, and elaborately painted coffered ceilings. We couldn't be more pleased with this acquisition and we look forward to providing the building with an even greater sense of purpose and a further restored life.”

For more information about Wolfe Investments, please visit

About Wolfe Investments

Founded in 2012, Wolfe Investments is a real estate investment firm dedicated to creating passive income for investors through a diverse portfolio of opportunities. The company has invested in over 5,000 units with an impressive worth of over $250MM and has been involved in $344,000,000 worth of real estate transactions.

Kenny Wolfe
Wolfe Investments
+1 972-599-0661
email us here

Source: EIN Presswire

Investors are Betting Big on Fantasy Sports

Fantasy sports and the betting industry is buzzing with investment activity with both big name-brands and start-up operators.

CHICAGO, IL, USA, March 31, 2021 / — It has been a busy year for fantasy sports and betting operators. The trailing 12 months have seen numerous mergers and acquisitions, public debuts ($DKNG), SPAC rumors ($HZON), and product launches from some of the biggest players in the industry.

Beyond the public deals, investments are also up significantly in the private sector.

“Over the last year, our clients and their financial backers have invested roughly $1M for start-up fantasy and betting projects with DreamCo Design. Hybrid style websites and apps that are focused on proving concept while limiting their regulatory costs are all the hype. Beyond our development contracts, we’ve also seen a big increase with inquiries. Casino brands, VC groups, and entrepreneurs have all reached out. The feedback we’ve gotten from data companies and various lawyers we work with in the industry also seems to imply there has been a big uptick.” – Jay Correia

Correia also noted numerous other private sector platforms that have launched or have acquired new rounds of funding in recent months; ranging from player prop picking parlay contests to season-long best-ball draft products.

The first large gathering of industry professionals since the COVID-19 pandemic is also slated to occur on June 6th – 8th, 2021 in Frisco, TX for the Fantasy Sports & Gaming Association conference. The rapid evolution of gameplay and growth will likely be a hot topic.

Press Contact
DreamCo Design
email us here

Source: EIN Presswire


Beach Enclave Turks & Caicos Logo

Beach Enclave Turks & Caicos Logo

Beachfront Villa at Beach Enclave Grace Bay Turks & Caicos

Beachfront Villa at Beach Enclave Grace Bay Turks & Caicos

Beach House at Beach Enclave Long Bay

Beach House at Beach Enclave Long Bay

Privacy, exclusivity and five-star resort services in the Turks & Caicos are the ideal remedy for lockdown fatigue

The Turks & Caicos luxury segment is seeing an increase in visitation over last year, exemplifying just how much interest there is in the destination.”

— Beach Enclave Founder and CEO Vasco Borges.

PROVIDENCIALES, TURKS AND CAICOS, March 31, 2021 / — Premier luxury real estate developer and hospitality operator Beach Enclave Turks & Caicos is reporting strong sales and increased interest in its private villas and residences. Beach Enclave sold $65 million of real estate since the beginning of the pandemic, including sell-out projects at Beach Enclave Grace Bay and Beach Enclave Long Bay Phase 2 in 2020; and in 2021, year-to-date, the company has already exceeded the total volume of sales from 2020.

Beach Enclave has been the leader in villa sales above $3 million in the Turks & Caicos Islands for the past four consecutive years. Every project to date has sold out within 24 months of land acquisition. In 2020, Beach Enclave sold 10 villas and condominiums at an average price point of $3 million. In the first two months of 2021, the developer sold six villas at an average price point of over $5 million, thus greatly outpacing the prior year. Since its founding in 2013, the company has successfully completed three developments across Providenciales and has three other projects currently underway.

“During this time of continued uncertainty and stress, we know that many families are looking for easily accessible, secluded, safe retreats from urban areas and their primary homes,” said Beach Enclave Founder and CEO Vasco Borges. “In general, the Turks & Caicos luxury segment is seeing an increase in visitation over last year, exemplifying just how much interest there is in the destination. This is an added benefit for owners as the villas go into rental inventory when not in use, generating additional income.”

Beach Enclave is a fully integrated investor, developer, brand and manager of luxury villa resorts in oceanfront beach enclaves. Its exclusive lifestyle concept combines the best of both worlds, allowing owners and guests to enjoy the space, seclusion and conveniences of a private home, enhanced by the personalized services and amenities of a luxury five‐star resort.

For partnership and investment opportunities, please contact Vasco Borges, or Giulia Auricchio,

# # #

Beach Enclave redefines beachfront luxury living in the Turks & Caicos Islands through its three unique locations, all strategically positioned in private enclaves on the islands’ most beautiful beaches. Each beachfront location showcases breathtaking ocean views and enjoys the island’s gentle trade winds. Beach Enclave North Shore debuted in November 2016 with a combination of six beachfront and three ocean view villas. Beach Enclave Long Bay opened for rentals in November 2018 and offers an intimate collection of five beachfront villas. Beach Enclave Grace Bay broke ground in February 2018 and opened this winter with nine new villas. The resort is the first opening on the world’s #1 Grace Bay Beach in the past decade. For additional information, visit

Claire Kunzman
Media Contact/PR Representative
email us here

Source: EIN Presswire

C4 Imaging Announces Addition to Board of Directors

C4 Imaging LLC, an early-stage medical device company, has announced that Jeff Seavey has been elected to the company's Board of Directors.

We are pleased to welcome Jeff to our Board at an important time for C4 Imaging. Jeff is a highly respected and seasoned medical device leader and will be an excellent resource for the C4 team.”

— Andrew Bright

HOUSTON, TX, USA, March 31, 2021 / — C4 Imaging LLC, an early-stage medical device company, has announced that Jeff Seavey has been elected to the company's Board of Directors. Jeff joins the C4 Imaging Board with over 25 years of success in the development and commercialization of medical devices.

Jeff graduated from Texas A&M University with a BS in Engineering and he currently serves as President and CEO of MakrMed LLC. His previous experience includes a diverse blend of executive roles, research and development leadership, global sales and marketing success. He was President and CEO of Restore Surgical LLC, dba Instratek from 2007-2016, where he built a highly successful medical device manufacturing business, with a worldwide distribution network. Instratek was acquired by Stryker Corporation in 2016.

"We are pleased to welcome Jeff to our Board at an important time for C4 Imaging,” said Andrew Bright, C4 Imaging’s President and CEO. “Jeff is a highly respected and seasoned medical device industry leader and will be an excellent resource for the C4 team as we prepare to launch Nova™, our recently FDA 510(k) cleared multimodality fiducial marker.”

"I am excited to join C4 Imaging’s Board," stated Mr. Seavey. "I look forward to working with my fellow Board members and company management to help deliver the benefits of C4’s unique positive-signal MRI technology to the many cancer patients who would benefit from it."

For further information:

Andrew Bright
Tel: 609 933 5895


C4 Imaging develops medical devices that enable clinicians to more accurately perform image-guided procedures. The company’s proprietary technology, C4, has been developed as Sirius®, a positive-signal MRI marker designed to improve quality assessment after prostate cancer treatment with brachytherapy, as well as Orion™, an MRI marker that enables accurate MRI–based pre-treatment planning for cancer patients being treated with high dose rate (HDR) brachytherapy. Sirius® and Orion™ enable the adoption of MARS – MRI-Assisted RadioSurgery. C4’s multimodality fiducial marker, Nova™, was recently FDA cleared and will be launched in 2021; Nova™ will allow the benefits of positive-signal MRI treatment management to be offered to the hundreds of thousands of patients who receive radiotherapy each year. C4 are currently developing non-metallic, positive MRI signal products specifically designed for the breast cancer biopsy market. To learn more, please visit Join us on Facebook/siriusmri.

Copyright © 2021
Orion, Sirius and Nova are trademarks of C4 Imaging

Andrew Bright
C4 Imaging
+1 6099335895
Visit us on social media:

Source: EIN Presswire

ChinaBio® Partnering Forum goes hybrid in May to accelerate cross-border life science partnerships globally

ChinaBio® Partnering Forum | May 10–14, 2021 | Shanghai and Digital

ChinaBio® Partnering Forum | May 10–14, 2021 | Shanghai and Digital

ChinaBio® Partnering Forum | Two days in-person

ChinaBio® Partnering Forum | Two days in-person

ChinaBio Partnering Forum | Three days virtually

ChinaBio Partnering Forum | Three days virtually

CARLSBAD, CA, UNITED STATES, March 31, 2021 / — The thirteenth annual ChinaBio® Partnering Forum will be held May 10–14, 2021, in a hybrid format; two days in-person in Shanghai, three days virtually, with a global reach enabling unprecedented partnering opportunities between companies worldwide and China’s fastest growing international healthcare market. The event is the largest and most well-established life science partnering conference spotlighting China, and its expanded five-day format with longer hours during the virtual portion of the event will allow widespread participation.

Registration and partnering details are available online.

“This is a prime time to take advantage of valuable opportunities with new partners and investors in China, without having to travel,” said Greg B. Scott, Founder and Chairman, ChinaBio® Group. “The event is the most important in China for connecting pharma and investors with China innovation and manufacturing, featuring a strong increase in important licensing deals with Western companies.”

“At a time when face-to-face interactions continue to be limited, we must find new approaches and creative solutions for fostering and maintaining the critical relationships that drive life science partnering, company growth and much needed therapeutics forward,” said Tina Gunnink, Managing Director, EBD US. “Our unparalleled partnering system facilitates seamless virtual meetings across the world through a video platform that allows person-to-person partnering.”

Companies, organizations and researchers interested in presenting their technologies or products available for partnering can apply to present now. Presentations will be pre-recorded and available to all registered delegates before and during the event.

ChinaBio® Partnering Forum is hosted by ATLATL and sponsored by Ascentage, BioDuro/Sundia, Bio2 Innovation Center, Boehringer Ingelheim, Cooley, Cytovance Biologics, Flanders Investment & Trade, Global Victoria, Hitgen, Johnson & Johnson Innovation, Luoxin, Morrison Foerster, MSD, Pfizer, PRA Health Sciences, Roche, Sanofi-Aventis Groupe, Shanghai Lingang Economic Development Group Technology Investment Co., Ltd., Vetter Pharma and Visen Pharma.

Attending companies from China and across the globe include pharma, biotech, innovative startups, and researchers from leading universities and institutes, as well as VCs and other industry stakeholders.

Partnering information for ChinaBio® Partnering Forum is available online. Registration rates increase on April 2, 2021, information is available online.

Follow ChinaBio® Partnering Forum on Twitter:  @EBDGroup (hashtag: #ChinaBioPartnering).


About EBD Group  
EBD Group's overriding mission is to help collaborations get started across the life science value chain. Our range of partnering conferences has grown to become the largest and most productive conference platform in the industry. Each one of our landmark events held in key life science markets around the world is powered by our state-of-the-art partnering software, partneringONE®, that enables delegates to efficiently identify and engage with new opportunities via one-to-one meetings. 

Today our events (BIO-Europe®, BIO-Europe Spring®, BioPharm America™, Biotech Showcase™, China Showcase, Digital Medicine & Medtech Showcase, ChinaBio® Partnering Forum, Rare Disease Innovation and Partnering Summit, Imagine Health Summit, and BioEquity Europe) annually attract more than 15,000 senior life science executives who engage in over 50,000 one-to-one partnering meetings. These vital one-to-one engagements are the wellspring of deals that drive innovation in our industry. 

 EBD Group is an Informa company. For more information please visit 

About ChinaBio® Group
Since its founding in 2007, ChinaBio® Group has successfully helped nearly 100 US, European and Asia-Pacific life science companies achieve success in China. Leveraging its consulting and advisory teams’ significant experience in China’s life science industry, ChinaBio® has helped its clients identify over 1,000 in-/out-licensing and M&A opportunities and raise over $500M in funding in China. Clients have included many global pharma and life science companies as well as early stage and mid-size companies in Europe, US, Korea and Japan, as well as China. ChinaBio® has also organized over 30 conferences in China focused on investment and partnering, and publishes ChinaBio® Today, the most widely read source for China life science news. ChinaBio® Group is headquartered in Shanghai with staff in San Diego, Silicon Valley, Canada and Switzerland.

Susanna Ling
EBD Group
+1 760-930-0500
email us here
Visit us on social media:

Source: EIN Presswire

GROWGENICS: Awarded Silicon Valley Review's Top 50 Leading Companies of the Year 2021

Growgenics Advanced Grow Lighting Leadership (left: Joe Anter, VP of Business Development; right: Rick Genga, CEO/President)

Growgenics Leadership (left: Joe Anter, VP of Business Development; right: Rick Genga, CEO/President)

Advanced horticultural LED grow light company GROWGENICS selected as one of The Silicon Review's 50 Leading Companies of the Year 2021 for their innovations.

EAST GREENWICH, RI, USA, March 31, 2021 / —

After having to adapt to the challenges that businesses across the country faced in 2020, Growgenics is thrilled to announce that they've been selected by The Silicon Review as one of their top 50 Leading Companies of 2021. They were selected for their advanced technology innovations, ability to adapt to the changing circumstances of the COVID-19 pandemic, and their extraordinary team of experts. Read below for an excerpt from The Silicon Review:

The Silicon Review

Energy efficiency continues to be a key factor for the adoption of LED technology in the horticulture sector. Controlled-environment agriculture (CEA) powered by LED lighting has been on the rise even before the onset of the COVID-19 pandemic. But the pandemic has now pushed this industry to grow faster as there is an increased demand for the CEA facilities. Horticultural lighting being integral to this form of agriculture, has also seen a significant rise in demand. The market is expected to continue growing. One of the foremost innovators in this segment is Growgenics; a leading advanced LED grow lighting company.

Founded in 2014, Growgenics has created advanced, patented horticultural LED grow lighting solutions for all species of plants worldwide. Its Founder and CEO, Richard Genga, a mechanical engineer and entrepreneur of 35+ years, designed the Growgenics lighting solutions to solve the problems associated with traditional grow lights. The company currently works with four major markets:

– Controlled environmental agriculture (CEA)
– Legal commercial cannabis cultivation
– Supplemental lighting for commercial greenhouses
– Horticultural University Research


Read more about Growgenics' innovations in grow lighting in the full feature at The Silicon Review:

The Growgenics Team
+1 401-250-5388
email us here
Visit us on social media:

Source: EIN Presswire